| Product NDC: | 0536-0825 |
| Proprietary Name: | Cough |
| Non Proprietary Name: | Guaifenesin |
| Active Ingredient(s): | 100 mg/5mL & nbsp; Guaifenesin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0536-0825 |
| Labeler Name: | Rugby Laboratories Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20091204 |
| Package NDC: | 0536-0825-85 |
| Package Description: | 473 mL in 1 BOTTLE (0536-0825-85) |
| NDC Code | 0536-0825-85 |
| Proprietary Name | Cough |
| Package Description | 473 mL in 1 BOTTLE (0536-0825-85) |
| Product NDC | 0536-0825 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Guaifenesin |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20091204 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Rugby Laboratories Inc. |
| Substance Name | GUAIFENESIN |
| Strength Number | 100 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes |